Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biopharmaceutical company developing therapeutics using ...

WASHINGTON — The Trump administration announced a deal Thursday to expand access to popular obesity drugs made by Novo Nordisk and Eli Lilly — offering more coverage for Medicare and Medicaid ...

Conroe-based bio-tech company VGXI Inc. has defaulted on its tax abatement agreement with Montgomery County and will pay more ...

A University of Bristol spinout that has developed a supplement to support people with Irritable Bowel Syndrome (IBS) has reached a major milestone. The biotech company Ferryx, which launched its ...

Demy-Colton's BioFuturetm 2025 conference wrapped up in New York and virtually this week, sounding a positive tone for the biotech industry and the technologies and trends transforming the future of ...

The field of biotechnology has always transformed cutting-edge science into life-changing medicines, but today that transformation is happening at a staggering pace.

THIRD QUARTER IN BRIEFActive Biotech provided status update for the development of laquinimod in inflammatory eye disorders and tasquinimod in hematological malignancies (July 8)Active Biotech present ...

Speculative activity surged across the micro-cap landscape during the third quarter, fueled by thematic momentum and outsized ...

The FDA approved darolutamide for mHSPC on June 3, [2025], so we now have this in our armamentarium, along with all the other ...

Vancouver, Canada, November 4th, 2025, FinanceWire Equity Insider News Commentary – The precision medicine sector reached ...

Datavault AI Inc. (“Datavault AI” or the “Company”) (Nasdaq: DVLT), a leader in AI-driven blockchain solutions focusing on data monetization, ...

Scilex Holding Company ("Scilex" or the "Company") (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing and commercializing ...